No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home News

Pfizer Faces Lawsuit for Covid Vaccine Lies

by
December 7, 2023
in News
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On this episode of Radio Rothbard, Ryan McMaken and Tho Bishop are joined by Dr. Gilbert Berdine, an associate professor of medicine at Texas Tech University Health Sciences Center and an affiliate of the Free Market Institute at Texas Tech University. In 2020, Dr. Berdine was warning about efficacy and risks claims being made over covid vaccines, which are at the forefront of a recent lawsuit by the State of Texas against Pfizer. Ryan and Tho discuss the case with Dr. Berdine, as well as the lessons learned from the government’s response to covid and what is fueling the authoritarian capture of the American medical industry.

“What the Covid Vaccine Hype Fails to Mention” by Gilbert Berdine: Mises.org/RR_163_A

“United Kingdom Mortality Data by Age Group and Vaccination Status: Looking at Vaccine Effectiveness” by Gilbert Berdine: Mises.org/RR_163_B

“Real Scientific Inquiry Requires Dissent. But That’s Not What the CDC and JAMA Want.” by Gilbert Berdine: Mises.org/RR_163_C

“Can Austrian Economics Save Medicine?” by DR. MICHEL ACCAD: Mises.org/RR_163_D

Claim your free book: Mises.org/RothPodFree

Be sure to follow Radio Rothbard at Mises.org/RadioRothbard.

Radio Rothbard mugs are now available at the Mises Store. Get yours at Mises.org/RothMug 

PROMO CODE: RothPod for 20% off

Previous Post

Defund the (Diversity) Police

Next Post

Lew Rockwell on NOW with Bill Moyers

Next Post

Lew Rockwell on NOW with Bill Moyers

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023

China’s Strengths Are Over-Exaggerated

0

0

0

0

China’s Strengths Are Over-Exaggerated

June 7, 2025

Paul Heyne: The Ethicist Who Thought Like an Economist

June 7, 2025

Preparing for War

June 7, 2025
I Shot the Tariff (But I Swear It Was in Self-Defense)

I Shot the Tariff (But I Swear It Was in Self-Defense)

June 6, 2025

Recent News

China’s Strengths Are Over-Exaggerated

June 7, 2025

Paul Heyne: The Ethicist Who Thought Like an Economist

June 7, 2025

Preparing for War

June 7, 2025
I Shot the Tariff (But I Swear It Was in Self-Defense)

I Shot the Tariff (But I Swear It Was in Self-Defense)

June 6, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.